Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Optinose Inc (NQ: OPTN )

4.190 USD -0.050 (-1.18%)
Official Closing Price Updated: 4:23 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Optinose Inc

< Previous 1 2 3 4 5 Next >
51 Stocks Moving In Tuesday's Mid-Day Session
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares climbed 123% to $6.11 following an announcement concerning its foray ... 
Tags NVAX Market News MXL
From Benzinga
81 Biggest Movers From Yesterday
Gainers Electrameccanica Vehicles Corp. (NASDAQ: SOLO) climbed 64.5% to close at $5.15 on Monday after jumping more than 34% on ... 
Tags BMA LMND EVSI
From Benzinga
62 Stocks Moving In Monday's Mid-Day Session
Gainers Ayro, Inc. (NASDAQ: AYRO) shares jumped 105.8% to $6.73 after the company completed its factory expansion that will allow ... 
Tags Benzinga WB Penny Stocks
From Benzinga
Grab This Deal Even Lower Than Director Scodari Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 6, OptiNose Inc's Director, Joseph C.. 
Tags Stocks
From Market News Video
OPTN Crosses Below Key Price/Book Valuation Level
In trading on Wednesday, shares of OptiNose Inc (OPTN) crossed below their last reported book value — defined as common shareholder equity per share — of $7.00, changing hands as low as $6.81 per... 
Tags Stocks
From Market News Video
65 Biggest Movers From Yesterday
Gainers Polar Power, Inc. (NASDAQ: POLA) shares surged 262% to close at $4.96 on Tuesday after jumping around 9% on ... 
Tags TRIB MCF Pre/Market Outlook
From Benzinga
51 Stocks Moving In Tuesday's Mid-Day Session
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares jumped 118% to $1.2750 after the company said that following a ... 
Tags ITRM CARV CLSK
From Benzinga
Peek Under The Hood: IBB Has 14% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
OptiNose (OPTN) Shares Cross Above 200 DMA
In trading on Tuesday, shares of OptiNose Inc (OPTN) crossed above their 200 day moving average of $6.78, changing hands as high as $6.85 per share. OptiNose Inc shares are currently trading up about... 
Tags Stocks
From Market News Video
Analysts Anticipate VTHR To Hit $146
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
OptiNose, Inc. (OPTN) Q1 2020 Earnings Call Transcript
OPTN earnings call for the period ending March 31, 2020. 
Tags Market News OPTN
From Motley Fool
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags APYX BMY NTLA
From Benzinga
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags DRNA SVRA GBT
From Benzinga
Analysts Predict 51% Gains Ahead For The Holdings of IWC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags ZTS NVCN ONTX
From Benzinga
Analysts Expect 50% Upside For IWV
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags Earnings DMPI NBRV
From Benzinga
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags RTRX HSDT PLXP
From Benzinga
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags TROV FDA TRPX
From Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 2568 stocks hit new 52-week lows. Areas of Significance: Amazon.com(NASDAQ: AMZN)is the largest company ... 
Tags DKL AVD DENN
From Benzinga
OptiNose, Inc. (OPTN) Q4 2019 Earnings Call Transcript
OPTN earnings call for the period ending December 31, 2019. 
Tags Market News OPTN
From Motley Fool
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SNDX CRVS OCUL
From Benzinga
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 ... 
Tags KIDS XBI DRRX
From Benzinga
Investors Snatch OPTN 32.3% Cheaper Than Its Secondary Stock Offering
Looking back to 95 days ago, OptiNose Inc (OPTN) priced a 5,500,000 share secondary stock offering at $9.75 per share. Buyers in that offering made a considerable investment into the company, expecting... 
Tags Stocks
From Market News Video
OptiNose is Now Oversold (OPTN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Sum Up The Parts: BIB Could Be Worth $73
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Land This Bargain Even Cheaper Than Director Scodari Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 6, OptiNose Inc's Director, Joseph C.. 
Tags Stocks
From Market News Video
60 Biggest Movers From Friday
Gainers LAIX Inc. (NYSE: LAIX) shares jumped 85.5% to close at $7.68 on Friday. Marinus Pharmaceuticals Inc (NASDAQ: MRNS) ... 
Tags OPTN Top Gainers ABUS
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 18, 2019
Upgrades JP Morgan upgraded the stock for Alexandria Real Estate Equities Inc (NYSE: ARE) from Neutral to Overweight. For the ... 
Tags HAL ESS IIVI
From Benzinga
IBB's Holdings Imply 18% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.